Contact
searchSearch
HMP Global

Advertisement

Advertisement

ADVERTISEMENT

Diabetes Topic Center

Featured Article

Headshots
Videos
How Digital Therapeutics Are Changing Disease Management, Diabetes Care
09/13/2023

Featuring Daniel Sontupe, Todd Prewitt, MD, and Yash Prajapati

Featuring Daniel Sontupe, Todd Prewit...
In this roundtable, Daniel Sontupe, managing director, The Bloc Value Builders, moderates a conversation with Todd Prewitt, MD, corporate medical director, value-based health strategies, Humana, and Yash Prajapati, consultant, ZS, about...
In this roundtable, Daniel Sontupe, managing director, The Bloc Value Builders, moderates a conversation with Todd Prewitt, MD, corporate medical director, value-based health strategies, Humana, and Yash Prajapati, consultant, ZS, about...
In this roundtable, Daniel...
09/13/2023
First Report Managed Care
Headshot of Courtney Quinn, Navitus Health Solutions
Interview
Switching to Biosimilars Yields Significant Cost Savings For Patients Taking Insulin
04/13/2023
Maria Asimopoulos
Courtney Quinn, PharmD, PGY1 pharmacy resident, Navitus Health Solutions, examined potential cost saving trends if individuals enrolled in 4 large commercial health plans switched from reference product insulin glargine to biosimilars.
Courtney Quinn, PharmD, PGY1 pharmacy resident, Navitus Health Solutions, examined potential cost saving trends if individuals enrolled in 4 large commercial health plans switched from reference product insulin glargine to biosimilars.
Courtney Quinn, PharmD, PGY1...
04/13/2023
First Report Managed Care
News
HHS Report Suggests Significant Member Cost Savings With $35 Insulin Cap
01/26/2023
Maria Asimopoulos
If the price cap had been implemented in 2020, it would have resulted in significant savings for Medicare Part B and Part D beneficiaries over the course of the year, the report suggests.
If the price cap had been implemented in 2020, it would have resulted in significant savings for Medicare Part B and Part D beneficiaries over the course of the year, the report suggests.
If the price cap had been...
01/26/2023
First Report Managed Care
Headshot of Ann Latner, JD
Commentary
Kansas Attorney General Files Insulin Lawsuit Against Manufacturers, PBMs
01/17/2023
Ann W Latner, JD
Ann Latner shares details from a complaint which alleged several drug manufacturers and pharmacy benefit managers raised the prices of insulin in violation of Kansas's Consumer Protection Act.
Ann Latner shares details from a complaint which alleged several drug manufacturers and pharmacy benefit managers raised the prices of insulin in violation of Kansas's Consumer Protection Act.
Ann Latner shares details from a...
01/17/2023
Pharmacy Learning Network
From Pharmacy Learning Network
News
California Attorney General Sues Drugmakers Over Inflated Insulin Prices
01/13/2023

Angela Hart and Samantha Young, Kaiser Health News

Angela Hart and Samantha Young, Kaise...
The complaint alleges 3 pharmaceutical companies and 3 pharmacy benefit managers are violating California law by increasing the cost of insulin.
The complaint alleges 3 pharmaceutical companies and 3 pharmacy benefit managers are violating California law by increasing the cost of insulin.
The complaint alleges 3...
01/13/2023
First Report Managed Care
News
California Seeks to Launch Generic Drug Label to Reduce Insulin Costs
06/08/2022

Angela Hart, Kaiser Health News

Angela Hart, Kaiser Health News ...
Governor Gavin Newsom has asked lawmakers in California to fund CalRx, a state-owned generic drug label that would produce its own brand of insulin and other drugs to lower prices for consumers.
Governor Gavin Newsom has asked lawmakers in California to fund CalRx, a state-owned generic drug label that would produce its own brand of insulin and other drugs to lower prices for consumers.
Governor Gavin Newsom has asked...
06/08/2022
First Report Managed Care
News
$35 Insulin Cap Under Build Back Better Plan Faces Challenges
03/04/2022

Michael McAuliff, Kaiser Health News

Michael McAuliff, Kaiser Health News ...
Even though there is bipartisan and public support for a price cap on insulin, complications among Democrats and Republicans could delay legislation.
Even though there is bipartisan and public support for a price cap on insulin, complications among Democrats and Republicans could delay legislation.
Even though there is bipartisan...
03/04/2022
First Report Managed Care
News
Diabetes Drugs Cost Less Under Medicaid vs Marketplace Plans in Colorado
01/17/2022
Maria Asimopoulos
Medicaid-eligible patients with diabetes experienced lower total costs and higher utilization rates compared to those covered by Marketplace plans in Colorado.
Medicaid-eligible patients with diabetes experienced lower total costs and higher utilization rates compared to those covered by Marketplace plans in Colorado.
Medicaid-eligible patients with...
01/17/2022
First Report Managed Care
News
Treatment Lowers Diabetes Rate in Patients With Kidney Disease, Heart Failure
12/22/2021
Jolynn Tumolo
Recent findings indicated that dapagliflozin reduced the incidence of new-onset type 2 diabetes in patients who had conditions linked to insulin resistance.
Recent findings indicated that dapagliflozin reduced the incidence of new-onset type 2 diabetes in patients who had conditions linked to insulin resistance.
Recent findings indicated that...
12/22/2021
First Report Managed Care
News
Effectiveness of Various Type 2 Diabetes Agents Differs With Cardiorenal Outcome
12/20/2021
Jolynn Tumolo
Researchers compared various sodium glucose cotransporter 2 inhibitors and glucagon-like peptide 1 receptor agonists to determine their relative efficacy in improving cardiorenal outcomes in patients with type 2 diabetes.
Researchers compared various sodium glucose cotransporter 2 inhibitors and glucagon-like peptide 1 receptor agonists to determine their relative efficacy in improving cardiorenal outcomes in patients with type 2 diabetes.
Researchers compared various...
12/20/2021
First Report Managed Care
News
Glucokinase Activators Outperform Placebo in Patients With Type 2 Diabetes
11/24/2021
Jolynn Tumolo
“[Glucokinase activators] could be an attractive choice for the treatment of type 2 diabetes mellitus,” researchers wrote, adding that continued research was needed to understand long-term safety and efficacy.
“[Glucokinase activators] could be an attractive choice for the treatment of type 2 diabetes mellitus,” researchers wrote, adding that continued research was needed to understand long-term safety and efficacy.
“[Glucokinase activators] could...
11/24/2021
First Report Managed Care

Newsfeed

News
HHS Report Suggests Significant Member Cost Savings With $35 Insulin Cap
01/26/2023
Maria Asimopoulos
If the price cap had been implemented in 2020, it would have resulted in significant savings for Medicare Part B and Part D beneficiaries over the course of the year, the report suggests.
If the price cap had been implemented in 2020, it would have resulted in significant savings for Medicare Part B and Part D beneficiaries over the course of the year, the report suggests.
If the price cap had been...
01/26/2023
First Report Managed Care
News
California Attorney General Sues Drugmakers Over Inflated Insulin Prices
01/13/2023

Angela Hart and Samantha Young, Kaiser Health News

Angela Hart and Samantha Young, Kaise...
The complaint alleges 3 pharmaceutical companies and 3 pharmacy benefit managers are violating California law by increasing the cost of insulin.
The complaint alleges 3 pharmaceutical companies and 3 pharmacy benefit managers are violating California law by increasing the cost of insulin.
The complaint alleges 3...
01/13/2023
First Report Managed Care
News
California Seeks to Launch Generic Drug Label to Reduce Insulin Costs
06/08/2022

Angela Hart, Kaiser Health News

Angela Hart, Kaiser Health News ...
Governor Gavin Newsom has asked lawmakers in California to fund CalRx, a state-owned generic drug label that would produce its own brand of insulin and other drugs to lower prices for consumers.
Governor Gavin Newsom has asked lawmakers in California to fund CalRx, a state-owned generic drug label that would produce its own brand of insulin and other drugs to lower prices for consumers.
Governor Gavin Newsom has asked...
06/08/2022
First Report Managed Care
News
$35 Insulin Cap Under Build Back Better Plan Faces Challenges
03/04/2022

Michael McAuliff, Kaiser Health News

Michael McAuliff, Kaiser Health News ...
Even though there is bipartisan and public support for a price cap on insulin, complications among Democrats and Republicans could delay legislation.
Even though there is bipartisan and public support for a price cap on insulin, complications among Democrats and Republicans could delay legislation.
Even though there is bipartisan...
03/04/2022
First Report Managed Care
News
Diabetes Drugs Cost Less Under Medicaid vs Marketplace Plans in Colorado
01/17/2022
Maria Asimopoulos
Medicaid-eligible patients with diabetes experienced lower total costs and higher utilization rates compared to those covered by Marketplace plans in Colorado.
Medicaid-eligible patients with diabetes experienced lower total costs and higher utilization rates compared to those covered by Marketplace plans in Colorado.
Medicaid-eligible patients with...
01/17/2022
First Report Managed Care
News
Treatment Lowers Diabetes Rate in Patients With Kidney Disease, Heart Failure
12/22/2021
Jolynn Tumolo
Recent findings indicated that dapagliflozin reduced the incidence of new-onset type 2 diabetes in patients who had conditions linked to insulin resistance.
Recent findings indicated that dapagliflozin reduced the incidence of new-onset type 2 diabetes in patients who had conditions linked to insulin resistance.
Recent findings indicated that...
12/22/2021
First Report Managed Care
News
Effectiveness of Various Type 2 Diabetes Agents Differs With Cardiorenal Outcome
12/20/2021
Jolynn Tumolo
Researchers compared various sodium glucose cotransporter 2 inhibitors and glucagon-like peptide 1 receptor agonists to determine their relative efficacy in improving cardiorenal outcomes in patients with type 2 diabetes.
Researchers compared various sodium glucose cotransporter 2 inhibitors and glucagon-like peptide 1 receptor agonists to determine their relative efficacy in improving cardiorenal outcomes in patients with type 2 diabetes.
Researchers compared various...
12/20/2021
First Report Managed Care
News
Glucokinase Activators Outperform Placebo in Patients With Type 2 Diabetes
11/24/2021
Jolynn Tumolo
“[Glucokinase activators] could be an attractive choice for the treatment of type 2 diabetes mellitus,” researchers wrote, adding that continued research was needed to understand long-term safety and efficacy.
“[Glucokinase activators] could be an attractive choice for the treatment of type 2 diabetes mellitus,” researchers wrote, adding that continued research was needed to understand long-term safety and efficacy.
“[Glucokinase activators] could...
11/24/2021
First Report Managed Care
News
A Third of COVID-19 Deaths Linked With Diabetes, Hypertension, Obesity, or Smoking
11/15/2021
Jolynn Tumolo
“These findings support that people with diabetes, hypertension, [and] obesity should be prioritized for vaccination in order to limit the higher death rates in hospital,” researchers wrote.
“These findings support that people with diabetes, hypertension, [and] obesity should be prioritized for vaccination in order to limit the higher death rates in hospital,” researchers wrote.
“These findings support that...
11/15/2021
First Report Managed Care
News
Medicare Patients From Racial/Ethnic Minority Groups Have Inadequate Access to MDPP
11/09/2021
Jolynn Tumolo
“The disproportionate burden of obesity and type 2 diabetes on racial and ethnic minority communities signals an urgent need to accelerate the implementation and coordination of the MDPP,” researchers wrote. 
“The disproportionate burden of obesity and type 2 diabetes on racial and ethnic minority communities signals an urgent need to accelerate the implementation and coordination of the MDPP,” researchers wrote. 
“The disproportionate burden of...
11/09/2021
First Report Managed Care
News
Keratoconus Appears to be Associated With Demodex Mites
05/16/2024
Jolynn Tumolo
Keratoconus, an eye disorder that leads to gradual curvature of the cornea, may be associated with Demodex infestation, suggests a small study published in the Oman Journal of Ophthalmology.
Keratoconus, an eye disorder that leads to gradual curvature of the cornea, may be associated with Demodex infestation, suggests a small study published in the Oman Journal of Ophthalmology.
Keratoconus, an eye disorder...
05/16/2024
First Report Managed Care
News
Hospital Costs May Be Higher for Patients With Private Insurance
05/14/2024
Hannah Musick
A recent research report reveals that individuals with private health insurance pay 254% more for hospital procedures than Medicare rates, leading to potentially increased costs for millions of Americans.
A recent research report reveals that individuals with private health insurance pay 254% more for hospital procedures than Medicare rates, leading to potentially increased costs for millions of Americans.
A recent research report reveals...
05/14/2024
First Report Managed Care
News
Study Finds No Treatment-Related Adverse Events in Boys Treated With Purified FIX Concentrate
05/09/2024
Jolynn Tumolo
Purified factor IX (FIX) concentrate was effective in treating and preventing bleeding episodes in real-world pediatric patients 6 years and younger with hemophilia B, according to a study published in the Journal of Blood Medicine.
Purified factor IX (FIX) concentrate was effective in treating and preventing bleeding episodes in real-world pediatric patients 6 years and younger with hemophilia B, according to a study published in the Journal of Blood Medicine.
Purified factor IX (FIX)...
05/09/2024
First Report Managed Care
News
Demodex Infestation Found in 9 of 10 Eye Clinic Patients Using 2-Minute Technique
05/09/2024
Jolynn Tumolo
Demodex mites were found in the eyelashes of 94% of patients examined with a simple diagnostic technique at a standard ophthalmic practice, according to a study published online in the journal Clinical Ophthalmology.
Demodex mites were found in the eyelashes of 94% of patients examined with a simple diagnostic technique at a standard ophthalmic practice, according to a study published online in the journal Clinical Ophthalmology.
Demodex mites were found in the...
05/09/2024
First Report Managed Care
News
Debate Emerges Over FDA's Plan to Regulate Laboratory Medical Tests
05/03/2024
Hannah Musick
The FDA's new regulations on laboratory-developed tests have sparked debate over access to innovative tests and patient care in the medical field, with opponents arguing that increased oversight could hinder the development of crucial new...
The FDA's new regulations on laboratory-developed tests have sparked debate over access to innovative tests and patient care in the medical field, with opponents arguing that increased oversight could hinder the development of crucial new...
The FDA's new regulations on...
05/03/2024
First Report Managed Care
News
Analysis Shows Proposed CMS ‘Best Price’ Rule May Increase Rebate Liability, Impacting Medicaid
04/26/2024
Dean Celia
A proposed rule from Centers for Medicare & Medicaid Services (CMS), “Misclassification of Drugs, Program Administration and Program Integrity Updates Under the Medicaid Drug Rebate Program,” has been in the spotlight recently. Major health...
A proposed rule from Centers for Medicare & Medicaid Services (CMS), “Misclassification of Drugs, Program Administration and Program Integrity Updates Under the Medicaid Drug Rebate Program,” has been in the spotlight recently. Major health...
A proposed rule from Centers for...
04/26/2024
First Report Managed Care
News
Rebalancing Coagulation Pathways and Human Factor 9 Gene Knock-In Strategy Identified for Hemophilia B
04/25/2024

Grace Taylor

Grace Taylor
A study published in Molecular Therapy Nucleic Acids highlights a treatment strategy for treating hemophilia B by combining rebalancing coagulation pathways and human factor 9 (hF9) gene knock-in (KI) using a lipid nanoparticle and...
A study published in Molecular Therapy Nucleic Acids highlights a treatment strategy for treating hemophilia B by combining rebalancing coagulation pathways and human factor 9 (hF9) gene knock-in (KI) using a lipid nanoparticle and...
A study published in Molecular...
04/25/2024
First Report Managed Care
News
Neurologist Recognized for Pioneering MS Research and Treatment Strategies
04/24/2024
Hannah Musick
Dr Rhonda Voskuhl received the 2024 John Dystel prize for her groundbreaking research on sex differences in multiple sclerosis (MS), advancing women's health.
Dr Rhonda Voskuhl received the 2024 John Dystel prize for her groundbreaking research on sex differences in multiple sclerosis (MS), advancing women's health.
Dr Rhonda Voskuhl received the...
04/24/2024
First Report Managed Care
News
Chicago Sky Blue May be Considered as a Diagnostic Stain for Visualizing Demodex in Patients With Demodex Blepharitis
04/24/2024
Lisa Kuhns, PhD
Chicago sky blue is a promising stain that can identify and quantify the number of Demodex mites in patients with Demodex blepharitis, according to a study published in PeerJ.
Chicago sky blue is a promising stain that can identify and quantify the number of Demodex mites in patients with Demodex blepharitis, according to a study published in PeerJ.
Chicago sky blue is a promising...
04/24/2024
First Report Managed Care
News
Adverse Events Common With Glucocorticoids for Polymyalgia Rheumatica
04/17/2024
Jolynn Tumolo
Although glucocorticoid treatment reduced inflammatory parameters in real-world patients with polymyalgia rheumatica (PMR), more than a third still showed above-normal levels throughout a 52-week follow-up period, according to study results...
Although glucocorticoid treatment reduced inflammatory parameters in real-world patients with polymyalgia rheumatica (PMR), more than a third still showed above-normal levels throughout a 52-week follow-up period, according to study results...
Although glucocorticoid...
04/17/2024
First Report Managed Care

Advertisement

Insights

Headshots
Videos
How Digital Therapeutics Are Changing Disease Management, Diabetes Care
09/13/2023

Featuring Daniel Sontupe, Todd Prewitt, MD, and Yash Prajapati

Featuring Daniel Sontupe, Todd Prewit...
In this roundtable, Daniel Sontupe, managing director, The Bloc Value Builders, moderates a conversation with Todd Prewitt, MD, corporate medical director, value-based health strategies, Humana, and Yash Prajapati, consultant, ZS, about...
In this roundtable, Daniel Sontupe, managing director, The Bloc Value Builders, moderates a conversation with Todd Prewitt, MD, corporate medical director, value-based health strategies, Humana, and Yash Prajapati, consultant, ZS, about...
In this roundtable, Daniel...
09/13/2023
First Report Managed Care
Headshot of Courtney Quinn, Navitus Health Solutions
Interview
Switching to Biosimilars Yields Significant Cost Savings For Patients Taking Insulin
04/13/2023
Maria Asimopoulos
Courtney Quinn, PharmD, PGY1 pharmacy resident, Navitus Health Solutions, examined potential cost saving trends if individuals enrolled in 4 large commercial health plans switched from reference product insulin glargine to biosimilars.
Courtney Quinn, PharmD, PGY1 pharmacy resident, Navitus Health Solutions, examined potential cost saving trends if individuals enrolled in 4 large commercial health plans switched from reference product insulin glargine to biosimilars.
Courtney Quinn, PharmD, PGY1...
04/13/2023
First Report Managed Care
Headshot of Ann Latner, JD
Commentary
Kansas Attorney General Files Insulin Lawsuit Against Manufacturers, PBMs
01/17/2023
Ann W Latner, JD
Ann Latner shares details from a complaint which alleged several drug manufacturers and pharmacy benefit managers raised the prices of insulin in violation of Kansas's Consumer Protection Act.
Ann Latner shares details from a complaint which alleged several drug manufacturers and pharmacy benefit managers raised the prices of insulin in violation of Kansas's Consumer Protection Act.
Ann Latner shares details from a...
01/17/2023
Pharmacy Learning Network
Headshot of German Hernandez, fellow of the American Society of Nephrology
Commentary
Diabetes Awareness Month: Nutrition Tips for Managing Type 2 Diabetes and ADPKD
11/18/2021

German Hernandez, MD, FASN contributor

German Hernandez, MD, FASN contributo...
German Hernandez, MD, provides nutrition tips for patients living with autosomal dominant polycystic kidney disease and stresses that “incorporating them into a patient’s routine as soon as diagnosis is confirmed may make a difference in...
German Hernandez, MD, provides nutrition tips for patients living with autosomal dominant polycystic kidney disease and stresses that “incorporating them into a patient’s routine as soon as diagnosis is confirmed may make a difference in...
German Hernandez, MD, provides...
11/18/2021
First Report Managed Care
Improved Reimbursement Options Needed for National Diabetes Prevention Program Providers
Interview
Improved Reimbursement Options Needed for National Diabetes Prevention Program Providers
03/17/2020
Jennifer Torres Mosst, PhD, program manager of Diabetes Strategies at the Division of Chronic Disease and Injury Prevention, explain why billing and reimbursement approaches play a critical role in the types of programs that can be...
Jennifer Torres Mosst, PhD, program manager of Diabetes Strategies at the Division of Chronic Disease and Injury Prevention, explain why billing and reimbursement approaches play a critical role in the types of programs that can be...
Jennifer Torres Mosst, PhD,...
03/17/2020
First Report Managed Care
Among Diabetes Patients, Cost Increases Linked With Guideline Non-Compliance
Interview
Among Diabetes Patients, Cost Increases Linked With Guideline Non-Compliance
03/10/2020
Swapnil Rajpathak, executive director cardiometabolic team, Center for Observational Real World Evidence, Merck & Co, Inc, discusses the importance of adherence to evidence-based care guidelines to improve health outcomes and reduce costs.
Swapnil Rajpathak, executive director cardiometabolic team, Center for Observational Real World Evidence, Merck & Co, Inc, discusses the importance of adherence to evidence-based care guidelines to improve health outcomes and reduce costs.
Swapnil Rajpathak, executive...
03/10/2020
First Report Managed Care
Interview
Improving Multiple Outcomes With One Treatment
07/09/2019
Kiersten Combs, vice president of US Cardiovascular & Metabolic Disease, and Jim McDermott, vice president of US Medical Affairs and Metabolism, both at AstraZeneca, highlight how the use of Farxiga and other SGLT2 inhibitors impact payers...
Kiersten Combs, vice president of US Cardiovascular & Metabolic Disease, and Jim McDermott, vice president of US Medical Affairs and Metabolism, both at AstraZeneca, highlight how the use of Farxiga and other SGLT2 inhibitors impact payers...
Kiersten Combs, vice president...
07/09/2019
First Report Managed Care
Interview
Social Risk Adjustment Important for Alternative Payment Model Success, Health Outcomes
04/17/2019
Christina Nguyen, senior research analyst, and Mary Beth Landrum, PhD, professor of health care policy, both at Harvard Medical School, explain why inadequate risk adjustment could counterproductively reduce payments to groups whose patient...
Christina Nguyen, senior research analyst, and Mary Beth Landrum, PhD, professor of health care policy, both at Harvard Medical School, explain why inadequate risk adjustment could counterproductively reduce payments to groups whose patient...
Christina Nguyen, senior...
04/17/2019
First Report Managed Care

Interactive Features

Advertisement

Advertisement

Advertisement

FRMC Volume 21, Issue 1

Current Issue

March 2024
Volume 21
Issue 1
Current Issue
Issue Archive

Advertisement

What's Trending?

News
CMS Issues Rules on Loss Ratios for Medicare Plans
02/19/2013
02/19/2013
First Report Managed Care
Dr Kesty Headshot
Videos
A Dermatologist's Perspective on Demodex Blepharitis: Causes, Symptoms, and Treatment Options
10/19/2023

Featuring Katarina Kesty, MD, MBA, FAAD, Dermatologist and Medical Director at St. Petersburg Skin and Laser

Featuring Katarina Kesty, MD, MBA, FA...
Katarina Kesty, MD, MBA, FAAD, Dermatologist and Medical Director at St. Petersburg Skin and Laser, weighs in on Demodex blepharitis, a condition characterized by inflammation of the eyelid margin caused by an overpopulation of Demodex mites,...
Katarina Kesty, MD, MBA, FAAD, Dermatologist and Medical Director at St. Petersburg Skin and Laser, weighs in on Demodex blepharitis, a condition characterized by inflammation of the eyelid margin caused by an overpopulation of Demodex mites,...
Katarina Kesty, MD, MBA, FAAD,...
10/19/2023
First Report Managed Care
News
When Care Is Split Between Medicare And Medicaid: KHN Interview With Melanie Bella
02/24/2011
02/24/2011
First Report Managed Care
Soumya Vishwanath, PharmD
Commentary
Catching the Next Wave Advancing Health Care: Digital Therapeutics
05/06/2021
Soumya Vishwanath, PharmD, University of Massachusetts Medical School, discusses digital therapeutics, which she says is the next wave of patient care, and highlights why it’s essential to assess how these products may play a role in clinical...
Soumya Vishwanath, PharmD, University of Massachusetts Medical School, discusses digital therapeutics, which she says is the next wave of patient care, and highlights why it’s essential to assess how these products may play a role in clinical...
Soumya Vishwanath, PharmD,...
05/06/2021
Pharmacy Learning Network
News
Why Are Some Patients Still Paying for HIV Preventive Care?
03/04/2022

Sarah Varney, Kaiser Health News 

Sarah Varney, Kaiser Health News  ...
As of January 2021, HIV preventive care was supposed to be free in the United States, but there are patients still paying for treatment.
As of January 2021, HIV preventive care was supposed to be free in the United States, but there are patients still paying for treatment.
As of January 2021, HIV...
03/04/2022
First Report Managed Care

Video Insights

Headshots
Videos
How Digital Therapeutics Are Changing Disease Management, Diabetes Care
09/13/2023

Featuring Daniel Sontupe, Todd Prewitt, MD, and Yash Prajapati

Featuring Daniel Sontupe, Todd Prewit...
In this roundtable, Daniel Sontupe, managing director, The Bloc Value Builders, moderates a conversation with Todd Prewitt, MD, corporate medical director, value-based health strategies, Humana, and Yash Prajapati, consultant, ZS, about...
In this roundtable, Daniel Sontupe, managing director, The Bloc Value Builders, moderates a conversation with Todd Prewitt, MD, corporate medical director, value-based health strategies, Humana, and Yash Prajapati, consultant, ZS, about...
In this roundtable, Daniel...
09/13/2023
First Report Managed Care
Tejaswi Kompala
Videos
Personalizing Weight Loss Management With GLP-1 Agonists
04/05/2024

Featuring Tejaswi Kompala, MD, head of cardiometabolic clinical strategy, Teladoc 

Featuring Tejaswi Kompala, MD, head o...
Delve into the rising demand for anti-obesity medications, the complexities of obesity management, and the importance of personalized approaches in improving cardiometabolic health in this insightful interview.
Delve into the rising demand for anti-obesity medications, the complexities of obesity management, and the importance of personalized approaches in improving cardiometabolic health in this insightful interview.
Delve into the rising demand for...
04/05/2024
First Report Managed Care
Zaubler Headshot
Videos
Integrating Behavioral Health Services to Reduce ED Visits: Substance Use Disorder and Social Determinants of Health
03/27/2024

Featuring Tom Zaubler, MD, MPH, CMO at NeuroFlow

Featuring Tom Zaubler, MD, MPH, CMO a...
Join us for the continuation of an engaging two-part series showcasing an expert dedicated to reducing emergency department visits through the integration of behavioral health practices. Dr Zaubler will share invaluable insights into...
Join us for the continuation of an engaging two-part series showcasing an expert dedicated to reducing emergency department visits through the integration of behavioral health practices. Dr Zaubler will share invaluable insights into...
Join us for the continuation of...
03/27/2024
First Report Managed Care
Zaubler Headshot
Videos
Integrating Behavioral Health Services to Reduce ED Visits: Suicide Prevention and Preemptive Primary Care
03/25/2024

Featuring Tom Zaubler, MD, MPH, CMO at NeuroFlow

Featuring Tom Zaubler, MD, MPH, CMO a...
Come join us for the first installment of a captivating two-part series featuring an expert committed to minimizing emergency department visits through the implementation of behavioral health integrations. Dr Zaubler will offer valuable...
Come join us for the first installment of a captivating two-part series featuring an expert committed to minimizing emergency department visits through the implementation of behavioral health integrations. Dr Zaubler will offer valuable...
Come join us for the first...
03/25/2024
First Report Managed Care
Yash Prajapati
Videos
Navigating the Evolution of Digital Solutions in Health Care
02/27/2024

Featuring Yash Prajapati, consultant at ZS Associates 

Featuring Yash Prajapati, consultant ...
Join us in exploring the challenges and opportunities in the development, approval, and integration of digital therapeutic solutions with ZS Associates consultant Yash Prajapati.
Join us in exploring the challenges and opportunities in the development, approval, and integration of digital therapeutic solutions with ZS Associates consultant Yash Prajapati.
Join us in exploring the...
02/27/2024
First Report Managed Care
Mansur Shomali
Videos
Advancements and Challenges in Diabetes Management
02/27/2024

Featuring Mansur Shomali, MD, chief medical officer at Welldoc, endocrinologist at MedStar Health 

Featuring Mansur Shomali, MD, chief m...
Learn about the state of digital therapeutics for disease management such as diabetes care in terms of cost, outcomes, integration, and more with Dr Mansur Shomali, CMO at Welldoc.
Learn about the state of digital therapeutics for disease management such as diabetes care in terms of cost, outcomes, integration, and more with Dr Mansur Shomali, CMO at Welldoc.
Learn about the state of digital...
02/27/2024
First Report Managed Care
kevin cowart md
Videos
Costs and Benefits: How a New Cholesterol-Lowering Drug Compares to Others
10/24/2023

Featuring Kevin Cowart, PharmD, MPH, BCACP, CDCES

Featuring Kevin Cowart, PharmD, MPH, ...
Dr Kevin Cowart, assistant professor at the University of South Florida College of Pharmacy, discusses inclisiran, a new non-statin treatment for high cholesterol.
Dr Kevin Cowart, assistant professor at the University of South Florida College of Pharmacy, discusses inclisiran, a new non-statin treatment for high cholesterol.
Dr Kevin Cowart, assistant...
10/24/2023
First Report Managed Care
John Hennessy Headshot
Videos
Biosimilars, Explained
10/24/2023

Featuring John Hennessey, MBA

Featuring John Hennessey, MBA
In this video, John Hennessey, MBA, Valuate Health Consultancy, explains biosimilars in relation to cancer care: what they are, why they matter, and how they have and haven’t lived up to their promise.
In this video, John Hennessey, MBA, Valuate Health Consultancy, explains biosimilars in relation to cancer care: what they are, why they matter, and how they have and haven’t lived up to their promise.
In this video, John Hennessey,...
10/24/2023
First Report Managed Care
Videos
AVAHO 2023: Andrew Brunner, MD, Discusses Updates in MDS
10/20/2023

Featuring Andrew Brunner, MD

Featuring Andrew Brunner, MD
In this video, Dr Brunner reviews his recent discussion he held at the 2023 AVAHO Annual Meeting, and provides treatment updates in the treatment of MDS.
In this video, Dr Brunner reviews his recent discussion he held at the 2023 AVAHO Annual Meeting, and provides treatment updates in the treatment of MDS.
In this video, Dr Brunner...
10/20/2023
First Report Managed Care
Dr Kesty Headshot
Videos
A Dermatologist's Perspective on Demodex Blepharitis: Causes, Symptoms, and Treatment Options
10/19/2023

Featuring Katarina Kesty, MD, MBA, FAAD, Dermatologist and Medical Director at St. Petersburg Skin and Laser

Featuring Katarina Kesty, MD, MBA, FA...
Katarina Kesty, MD, MBA, FAAD, Dermatologist and Medical Director at St. Petersburg Skin and Laser, weighs in on Demodex blepharitis, a condition characterized by inflammation of the eyelid margin caused by an overpopulation of Demodex mites,...
Katarina Kesty, MD, MBA, FAAD, Dermatologist and Medical Director at St. Petersburg Skin and Laser, weighs in on Demodex blepharitis, a condition characterized by inflammation of the eyelid margin caused by an overpopulation of Demodex mites,...
Katarina Kesty, MD, MBA, FAAD,...
10/19/2023
First Report Managed Care

Subscribe to our eNewsletters!

First Report Managed Care Newsletter

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Privacy Policy Terms of Use

Advertisement

Advertisement